Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03793361
Title Phase II Study of Regorafenib as Maintenance Therapy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Oscar Lambret
Age Groups: adult | senior
Covered Countries FRA

No variant requirements are available.